• EU filing for CPP's familial adenomatous polyposis drug pharmatimes
    June 22, 2020
    US private biotech Cancer Prevention Pharmaceuticals has filed a marketing application in Europe for CPP-1X/sul, a preventative treatment for patients with familial adenomatous polyposis (FAP).
PharmaSources Customer Service